Abstract
Use of liposomal bupivacaine (Exparel®) in surgery is reported with decreased postoperative opioid requirements. The efficacy of liposomal bupivacaine versus standard bupivacaine injections at laparoscopic port sites during bariatric surgery is unknown.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have